ADAR1 Capital Management, LLC
302 holdingsFiling period: 2026-03-31Current AUM: $1.94Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | 1.44M | $160.1M | $179.6M | 9.26% | +120.7K | 2026-03-31 |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | 994.1K | $104.8M | $135.8M | 7.01% | -55,049 | 2026-03-31 |
| 3 | — | ROIVANT SCIENCES LTD | 3.29M | $91.0M | $91.0M | 4.69% | -143,056 | 2026-03-31 |
| 4 | IMVT | IMMUNOVANT INC | 2.68M | $66.5M | $103.5M | 5.34% | +198.0K | 2026-03-31 |
| 5 | TERN | TERNS PHARMACEUTICALS INC | 1.11M | $58.8M | $58.8M | 3.03% | +573.1K | 2026-03-31 |
| 6 | SPY | STATE STR SPDR S&P 500 ETF T | 75.9K | $49.4M | $56.7M | 2.93% | +21.3K | 2026-03-31 |
| 7 | CYTK | CYTOKINETICS INC | 632.6K | $41.7M | $48.8M | 2.52% | +92.4K | 2026-03-31 |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | 1.14M | $41.4M | $95.2M | 4.91% | +830.0K | 2026-03-31 |
| 9 | BOXX | EA SERIES TRUST | 337.1K | $39.2M | $39.7M | 2.05% | -- | 2026-03-31 |
| 10 | DNLI | DENALI THERAPEUTICS INC | 1.87M | $35.9M | $43.1M | 2.22% | +1.82M | 2026-03-31 |
| 11 | BEAM | BEAM THERAPEUTICS INC | 1.45M | $34.5M | $36.9M | 1.90% | -- | 2026-03-31 |
| 12 | ZLAB | ZAI LAB LTD | 1.43M | $26.8M | $26.0M | 1.34% | +178.8K | 2026-03-31 |
| 13 | SEPN | SEPTERNA INC | 1.09M | $26.2M | $37.5M | 1.94% | -67,793 | 2026-03-31 |
| 14 | VIR | VIR BIOTECHNOLOGY INC | 2.74M | $24.6M | $23.8M | 1.23% | -- | 2026-03-31 |
| 15 | DBVT | DBV TECHNOLOGIES S A | 1.01M | $21.2M | $13.7M | 0.71% | -- | 2026-03-31 |
| 16 | AVR | ANTERIS TECHNOLOGIES GLOBAL | 3.79M | $21.0M | $29.7M | 1.53% | +2.55M | 2026-03-31 |
| 17 | INSP | INSPIRE MED SYS INC | 405.2K | $20.9M | $20.3M | 1.05% | +390.2K | 2026-03-31 |
| 18 | SRRK | SCHOLAR ROCK HLDG CORP | 407.3K | $20.0M | $19.3M | 0.99% | +337.7K | 2026-03-31 |
| 19 | RYTM | RHYTHM PHARMACEUTICALS INC | 211.4K | $18.4M | $21.0M | 1.08% | +160.1K | 2026-03-31 |
| 20 | SYRE | SPYRE THERAPEUTICS INC | 338.3K | $17.1M | $33.3M | 1.72% | +304.3K | 2026-03-31 |
| 21 | CTMX | CYTOMX THERAPEUTICS INC. | 3.41M | $16.0M | $10.6M | 0.55% | -872,579 | 2026-03-31 |
| 22 | — | PROTHENA CORP PLC | 1.58M | $15.4M | $15.4M | 0.79% | +123.7K | 2026-03-31 |
| 23 | SNY | SANOFI SA | 316.9K | $15.3M | $13.7M | 0.70% | +253.5K | 2026-03-31 |
| 24 | PCVX | VAXCYTE INC | 259.1K | $15.1M | $14.0M | 0.72% | -56,505 | 2026-03-31 |
| 25 | MNPR | MONOPAR THERAPEUTICS INC | 264.3K | $14.5M | $28.6M | 1.48% | +30.4K | 2026-03-31 |
← Scroll →
Page 1 of 13